- Home
- SPCB vs TENX Comparison
SPCB vs TENX Comparison
Compare SPCB & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- TENX
- Stock Information
- Founded
- SPCB 1988
- TENX 1967
- Country
- SPCB Israel
- TENX United States
- Employees
- SPCB N/A
- TENX N/A
- Industry
- SPCB Semiconductors
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- TENX Health Care
- Exchange
- SPCB Nasdaq
- TENX Nasdaq
- Market Cap
- SPCB 21.1M
- TENX 21.6M
- IPO Year
- SPCB N/A
- TENX N/A
- Fundamental
- Price
- SPCB $11.99
- TENX $6.06
- Analyst Decision
- SPCB Strong Buy
- TENX Strong Buy
- Analyst Count
- SPCB 1
- TENX 3
- Target Price
- SPCB $18.00
- TENX $16.00
- AVG Volume (30 Days)
- SPCB 280.2K
- TENX 11.9K
- Earning Date
- SPCB 05-14-2025
- TENX 05-14-2025
- Dividend Yield
- SPCB N/A
- TENX N/A
- EPS Growth
- SPCB N/A
- TENX N/A
- EPS
- SPCB 1.89
- TENX N/A
- Revenue
- SPCB $27,831,000.00
- TENX N/A
- Revenue This Year
- SPCB $2.73
- TENX N/A
- Revenue Next Year
- SPCB $22.87
- TENX N/A
- P/E Ratio
- SPCB $5.70
- TENX N/A
- Revenue Growth
- SPCB 2.90
- TENX N/A
- 52 Week Low
- SPCB $2.55
- TENX $2.77
- 52 Week High
- SPCB $18.95
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SPCB 73.82
- TENX 55.80
- Support Level
- SPCB $8.80
- TENX $5.60
- Resistance Level
- SPCB $9.90
- TENX $6.31
- Average True Range (ATR)
- SPCB 0.97
- TENX 0.27
- MACD
- SPCB 0.30
- TENX -0.01
- Stochastic Oscillator
- SPCB 92.72
- TENX 63.31
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.